Warner Chilcott - All Press Releaseshttp://ir.wcrx.com/releases.cfm?sh_auth=0.0.0.ad1dcb691ef81696c0c02ea27e385165en-usShareholder.com RSS FeedAnnouncement Under Irish Takeover Rules Relevant Securities in Issuehttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=764142Mon, 13 May 2013 04:00:00 GMThttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=764142Announcement Under Irish Takeover Rules Relevant Securities in IssueWarner Chilcott Statement Regarding Market Speculationhttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=763937Fri, 10 May 2013 04:00:00 GMThttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=763937Warner Chilcott Statement Regarding Market SpeculationWarner Chilcott Reports Operating Results for the Quarter Ended March 31, 2013http://ir.wcrx.com/releasedetail.cfm?ReleaseID=763847Fri, 10 May 2013 04:00:00 GMThttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=763847Warner Chilcott Reports Operating Results for the Quarter Ended March 31, 2013Warner Chilcott Announces FDA Approval of New Oral Contraceptivehttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=763428Thu, 09 May 2013 04:00:00 GMThttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=763428Warner Chilcott Announces FDA Approval of New Oral ContraceptiveWarner Chilcott Declares Semi-Annual Cash Dividend of $0.25 Per Sharehttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=762805Tue, 07 May 2013 04:00:00 GMThttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=762805Warner Chilcott Declares Semi-Annual Cash Dividend of $0.25 Per ShareWarner Chilcott Announces Changes to Board of Directorshttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=761627Thu, 02 May 2013 04:00:00 GMThttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=761627Warner Chilcott Announces Changes to Board of DirectorsWarner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2013 Financial Resultshttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=761092Wed, 01 May 2013 04:00:00 GMThttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=761092Warner Chilcott Announces Earnings Release Date and Conference Call for First Quarter 2013 Financial ResultsWarner Chilcott Announces FDA Approval of New Oral Contraceptivehttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=758063Mon, 22 Apr 2013 04:00:00 GMThttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=758063Warner Chilcott Announces FDA Approval of New Oral ContraceptiveWarner Chilcott Announces FDA Approval of DORYX(R) Delayed-Release 200 mg Tabletshttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=756218Fri, 12 Apr 2013 04:00:00 GMThttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=756218Warner Chilcott Announces FDA Approval of DORYX(R) Delayed-Release 200 mg TabletsWarner Chilcott to Present at the 2013 Goldman Sachs Leveraged Finance Healthcare Conferencehttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=745028Mon, 04 Mar 2013 05:00:00 GMThttp://ir.wcrx.com/releasedetail.cfm?ReleaseID=745028Warner Chilcott to Present at the 2013 Goldman Sachs Leveraged Finance Healthcare Conference